* Note: Prices are in Million (M) USD.
Description:
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $69 M
Debt : $474 M
EBITDA : $-75 M
Net Debt (Debt - Cash): $404 M
Since Ebitda is less than 0, 0 points assigned.
This criteria used industry in which company operates:
Sector: Health Care
Industry: Medical Devices
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Message: Cannot calculate PE Ratio since EPS is either 0 or negative.
Using default values for calculation.
Forward PE Ratio (using default values): 20.00
Since Forward PE Ratio is between 20 - 25, 2 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $-26 M
Average Revenue: $327 M
Revenue Converted To Free Cash Flow (%): -8%
Avg Free Cash Flow Growth Per Year (Last 5 Years): -15.57%
Since Free Cash Flow (FCF) to Revenue percentage is non-positive, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $940 M
Revenue 4 Years Ago (2020-12-31): $499 M
Last 5 Years Average Revenue Growth: 18%
Since Revenue Growth is between 15 - 20, 4 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $65 M
Share Count 5 Years Ago (2020-12-31): $61 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Message: Cannot calculate payout ratio because EPS is either 0 or negative.
Using default values for calculation.
Based on default values, 1 points assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -56%
Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $12
52-Week Low: $14
Threshold Price (15% Above 52-Week Low): $16
Since Current price is within 15% threshold, 5 points assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $1,110 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 2% exposure of Total Portfolio.
Value-Trade has assigned 16 points to above Tandem Diabetes Care Inc (TNDM) stock.
Fair Value PE 12, Industry Based PE 18, Growth Based PE 17. Based on these 3 values, average assigned is 15.67.
The fair value of Tandem Diabetes Care Inc (TNDM) stock cannot be calculated since EBITDA and EPS are either 0 or negative.
